Fecal occult blood tests

Why This Topic Matters

Understanding the coverage and reporting framework for fecal occult blood testing helps practices avoid miscoding, determine when the service is bundled with preventive care, and respond appropriately to payer-specific instructions. The topic is especially important for ob/gyn and other outpatient practices that perform colorectal cancer screening or diagnostic stool testing.

Article Sections

1. Medicare coverage and test types

   Introduces Medicare coverage developments for stool-based blood testing and distinguishes the general categories of testing discussed in the article.

2. Sampling and carrier policy guidance

   Summarizes payer and carrier guidance about specimen collection practices and highlights that policies may differ by jurisdiction and testing context.

3. CLIA-waived reporting and preventive care billing

   Covers reporting considerations for laboratory testing, the role of a modifier discussion, and how screening performed during preventive visits may be handled.

4. Clinical handling and Medicare expansion of coverage

   Discusses practical concerns about in-office testing, specimen collection conditions, and Medicare’s broader coverage direction for stool-based blood tests.